Russell Frank Company’s Intermolecular, Inc. IMI Stock Holding History

Russell Frank Company’s Portfolio IMI Stock Details IMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-358,159	Closed	-$1M	–	2898
2014 Q1	$1M	Buy	+358,159	New	+$1.3M	﹤0.01%	2093
2013 Q4	–	Sell	-93	Closed	-$1K	–	3201
2013 Q3	$1K	Buy	93 +9	+11%	+$57	﹤0.01%	3415
2013 Q2	$1K	Buy	+84	New	+$715	﹤0.01%	3287

Other funds holding IMI

RCM

Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ERSOT

Employees Retirement System of Texas Austin, Texas $11.4B AUM 21.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Russell Frank Company's IMI Position: Q2 2014 in Review

Russell Frank Company sold out of Intermolecular, Inc. (IMI) in Q2 2014, closing a stake of 358,159 shares — an estimated $1M sold.

Russell Frank Company first reported a position in IMI in Q2 2013 and held it in 3 quarters. The position peaked at $1M in Q1 2014. 43 funds tracked by Wall St. Rank hold IMI as of Q2 2014.

Russell Frank Company reported no remaining Intermolecular, Inc. position as of Q2 2014 after selling out during the quarter.
Russell Frank Company sold 358,159 Intermolecular, Inc. shares in Q2 2014, an estimated $1M.
Russell Frank Company first reported a position in Intermolecular, Inc. in Q2 2013 and held it in 3 quarters.
Russell Frank Company's Intermolecular, Inc. position peaked at $1M in Q1 2014.
43 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q2 2014.

Based on Russell Frank Company's 13F filing for Q2 2014, filed 14 Aug 2014.